80621-90-5

Basic information

• Product Name: BOC-SAR-OSU
• Synonyms: N-ALPHA-T-BOC-SARCOSINE N-HYDROXYSUCCINIMIDE ESTER;BOC-SARCOSINE HYDROXYSUCCINIMIDE ESTER;BOC-SARCOSINE N-HYDROXYSUCCINIMIDE ESTER;BOC-SARCOSINE-OSU;BOC-SAR-OSU;BOC-N-ME-GLY-OSU;BOC-N-METHYLGLYCINE N-HYDROXYSUCCINIMIDE ESTER;Boc-Sar-OSu, Boc-MeGly-OSu
• CAS NO: 80621-90-5
• Molecular Formula: C₁₂H₁₈N₂O₆
• Molecular Weight: 286.28
• Product Categories: Amino Acids
• Mol File: 80621-90-5.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 377.9±35.0 °C(Predicted)
• Appearance: /
• Density: 1.28±0.1 g/cm3(Predicted)
• Storage Temp.: -15°C
• PKA: -1.79±0.70(Predicted)
• CAS DataBase Reference: BOC-SAR-OSU(CAS DataBase Reference)
• NIST Chemistry Reference: BOC-SAR-OSU(80621-90-5)
• EPA Substance Registry System: BOC-SAR-OSU(80621-90-5)

Safety Data

• Hazardous Substances Data: 80621-90-5(Hazardous Substances Data)

Usage

Chemical Properties

White to off-white powder

Upstream product

• 6066-82-6 1-hydroxy-pyrrolidine-2,5-dione 
• 13734-36-6 N-(tert-butoxycarbonyl)sarcosine 
• 58632-95-4 2-(tert-Butoxycarbonyloxyimino)-2-phenylacetonitrile 

Downstream Products

• 1532591-77-7 (3S,4S)-6-acetyl-4-[(3-chloro-4-fluorobenzene)amido]-2,2-dimethyl-3,4-dihydro-2H-1-benzopyran-3-yl 2-{[(tert-butoxy)carbonyl](methyl)amino}acetate 
• 1273017-03-0 C₂₂H₃₄N₂O₆ 
• 85574-68-1 Boc-Sar-Lys(Z)-Pro-OMe 
• 769950-62-1 ({3,5-bis-[2-(tert-butoxycarbonyl-methyl-amino)-acetylamino]-cyclohexylcarbamoyl}-methyl)-methyl-carbamic acid tert-butyl ester 
• 212756-39-3 2-[1-[2-(tert-butoxycarbonyl-methyl-amino)-acetylamino]-2-(4-fluoro-phenyl)-ethyl]-thiazole-4-carboxylic acid ethyl ester 
• 85574-70-5 Boc-Sar-Sar-Lys(Z)-Pro-OMe 

Relevant articles and documents

PRODRUG DERIVATIVES OF SUBSTITUTED TRIAZOLOPYRIDINES

The present invention relates to prodrug derivatives of Mps-1 kinase inhibitors, processes for their preparation, and their use for the treatment and/or prophylaxis of diseases.

CARBAPENEM ANTIBACTERIALS WITH GRAM-NEGATIVE ACTIVITY AND PROCESSES FOR THEIR PREPARATION

The present invention provides β-methyl carbapenem compounds and pharmaceutical compositions useful in the treatment of bacterial infections and methods for treating such infections using such compounds and/or compositions. The invention includes administ

Synthesis of N-urethane-protected γ-amino-functionalized butenoates and tautomeric studies by means of NMR, X-ray crystallography and ab initio calculations

N-Urethane-protected γ-amino-α-cyano-β-hydroxybutenoates were synthesized as potential statine analogues and the stability of their possible tautomers was assessed using NMR, X-ray crystallography and ab initio calculations. The results establish that the cis-enol tautomeric form is the most stable one both in solution (CDCl3) and in the solid phase. In full agreement with the experimental data, the theoretical calculations predicted that the cis-enol tautomer would be the minimum energy tautomer.